Loading provider…
Loading provider…
Surgery Physician in San Diego, CA
NPI: 1255501474Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Leslie's Phone Numberphone_androidMobile
Get M.D. Leslie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2027

American Board of Surgery
Surgery

American Board of Surgery
Surgical Critical Care
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Fellowship • Surgical Critical Care
2008 - 2009
Residency • Surgery
2003 - 2008
University of Colorado Anschutz Medical Campus
medschool.cuanschutz.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 64 | 127 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 46 | 101 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 32 | 32 |
| 4 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 24 | 64 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 |
Authors: Forrest Moore, Carlos Brown, Raul Coimbra, Matthew Carrick, Jason Murry, Galinos Barmparas, Patrick Bosarge, Stephen Kaminski, Eric Ley
Journal: J Trauma Acute Care Surg
Lead Sponsor: Atox Bio Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Reltecimod 0.5 mg/kg
Lead Sponsor: Atox Bio Ltd
Collaborators: Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: AB103 0.5 mg/kg, OTHER: NaCl 0.9%